NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » Comment » FDA approves treatment for refractory multiple myeloma despite health risks » drugs-1728381_960_720

FDA approves treatment for refractory multiple myeloma despite health risks

NS Medical Devices is using cookies

The drug, rimegepant, is awaiting FDA approval and may offer advantages over currently available migraine medications (Credit: Pixabay)

Related Article

What is a pulse oximeter and how is the device being used to combat Covid-19?

RECOMMENDED COMPANIES

MOST READ

European researchers are developing a new scanner to speed up detection of eye disease

What is a pulse oximeter and how is the device being used to combat Covid-19?

Q doctor poised to become biggest UK booking provider for Covid-19 vaccinations

Five of our favourite medical innovations from COMPAMED and MEDICA 2020

Six medical devices that help patients manage diabetes

Recommended Whitepaper